Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
Registered number: 05694721 Charity number: 1115555
THEATRE503 LIMITED
(A company limited by guarantee)
UNAUDITED
TRUSTEES' REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
CONTENTS
| Page | |
|---|---|
| Reference and administrative details of the Charity, its Trustees and advisers | 1 |
| Trustees' report | 2 - 8 |
| Trustees' responsibilities statement | 9 |
| Independent examiner's report | 10 |
| Statement of financial activities | 11 |
| Balance sheet | 12 - 13 |
| Statement of cash flows | 14 |
| Notes to the financial statements | 15 - 30 |
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 MARCH 2025
| Trustees | Erica Whyman OBE, Chair (stood down 27 November 2024) |
|---|---|
| Royce Bell, Vice Chair (stood down 11 June 2025) | |
| Joshua Chua | |
| James Dacre, Chair (appointed 27 November 2024) | |
| Eleanor Lloyd OBE (stood down 11 June 2025) | |
| Ollie Raggett | |
| Emma Rees, Vice Chair | |
| Jack Tilbury | |
| Zena Tuitt (stood down 27 November 2024) | |
| Roy Williams OBE | |
| Lisa Spirling Coleman (Artistic Director, stood down 23 January 2025) | |
| Naomi Kerbel | |
| Cerian Walsh (appointed 9 August 2024) | |
| Philippa Hill (appointed 1 August 2024) | |
| Tian Brown-Sampson, Associate Trustee (appointed 1 August 2024) | |
| Emily Carewe-Jeffries (Executive Director, appointed 23 January 2025) | |
| Naomi Alicia Ladenburg (appointed 1 August 2024) | |
| Kandy Chantal Rohmann (appointed 1 August 2025) | |
| Company registered number 05694721 Charity registered number 1115555 Registered and principal operating office 503 Battersea Park Road London SW11 3BW Executive Director Emily Carewe (appointed Co-CEO November 2024) Artistic Director Lisa Spirling (stepped down January 2025) Anthony Simpson-Pike (appointed February 2025) Independent Examiners MHA Chartered Accountants 2 London Wall Place London EC2Y 5AU |
Page 1
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
TRUSTEES' REPORT FOR THE YEAR ENDED 31 MARCH 2025
The Trustees present their annual report together with the financial statements of the Charity for the year ended 31 March 2025.
The Annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).
Since the Charity qualifies as small under section 382 of the Companies Act 2006, the Strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.
Objectives and activities
a. Policies and objectives
In shaping the theatre's objectives for the year and planning its activities, the Trustees have considered the Charity Commission's guidance on public benefit, including the guidance on public benefit and fee charging. The theatre relies on grants and the income from fees and charges to cover its operating costs.
In setting the level of fees, charges and concessions, the Trustees give careful consideration to the accessibility of the theatre for those on low incomes.
Affordability and access to the programme is important to Theatre503 and the work it produces is intended to be enjoyed by all ages, both locally, London and UK wide.
b. Strategies for achieving objectives
-
The strategies employed to achieve the charity's aims and objectives are to:
-
develop, produce, present, and support a wide variety of theatre productions for the enjoyment and education of a diverse audience demographic;
-
identify and support the very best debut and emerging writers to stage their first productions, performed to the highest professional standard;
-
break down all barriers to writing, staging, participating in and seeing theatre;
-
be the best practice model for early career playwrights and new writing practice through the Writers Programme and the 503Studio;
-
become a sustainable, dynamic, and flexible business able to adapt to an ever-changing future landscape.
Putting these strategies into action the theatre has three major areas of activity which are:
-
Stage productions; and
-
Literary development programmes (The Writers Programme); and
-
Participation and accessibility in the local community.
Page 2
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025
Objectives and activities (continued)
c. Activities for achieving objectives
This year saw a range of brilliant debut plays on our stage, encompassing a range of stories and lived experiences. We staged twenty nine 60+ minute productions, and twenty four 10-minute shorts across the year, engaging 363 freelance artists across our season.
Our Online Writers Programme continued to go from strength to strength. We continued our 3-term programme delivery, and expanded in-person delivery in early 2025 with the opening of the 503Studio. We engaged over 400 early career writers, and offered 30+ bursary discounted places across the programmes.
We opened submissions for the 2024/25 International Playwriting Award in spring 2024, receiving 1377 submissions from 49 countries. We continued to deliver our 503Five programme, working with writers Asa Haynes, Joe Kerridge, Melis Aker, Rachel Mae Brady and Shona Babayemi across the year on their debut play commissions.
This year we continued to feel the acute impact of a shift in application success rates for Arts Council England Project Funding from pre-pandemic to the current climate across the sector. The scarcity of funding opportunities led to a number of productions needing to be cancelled or postponed. Both Tachwedd and Bungalow were productions that had previously been programmed for 2023-2024, but had struggled to secure adequate funding therefore moving into the 2024-25 programme. This continued to pose challenges financially, as well as additional pressure on the team’s capacity as alternative productions, short runs or projects were developed to ensure our connections with participants, audiences and key stakeholders was not affected. As of late March 2025 we have made the decision to launch a new producing model for 2026/27, relying on less ACE funding and more commercial and philanthropic sponsorship and earned income so as to stabilise our programming and ensure each debut writer we launch has the best possible experience.
After 8 years in post, Artistic Director/CEO Lisa Spirling left Theatre503 in early January 2025 to take on the position of Artistic Director/Co-CEO at Stratford East. Lisa’s leadership has been transformational for Theatre503, including the specificity in our unique offering to the sector of only supporting debut playwrights, the securing of our lease at the 503Studio, and continuing the legacy of 503’s impact across the sector. To support the transition, Executive Director Emily Carewe was appointed Co-CEO from November 2024, and the role of Artistic Director was recruited as a Co-CEO role, embedding a new co-leadership model for Theatre503. Following a very competitive and rigorous recruitment process led by newly appointed Chair James Dacre and a selection committee of Trustees, Anthony Simpson-Pike (previously Deputy Director at The Yard and Associate Director at The Gate and Theatre Peckham) was appointed, taking up post from 10th February 2025.
Our progress towards opening the 503Studio continued. We completed phase 1 of the fit-out, including MEP installation (ventilation, plumbing, electrical) meaning we were able to open the building for meanwhile use in January 2025. The 503Studio continues to be operational and open for hires, rehearsals, workshops and The Writers Programme, providing vital added capacity and earned income potential. We have approximately £600k remaining to raise to complete phase 2 of the fit-out (estimated completion timeline of late 2026), but can continue to be operational and use the space meaningfully for rehearsals, workshops and development work until then.
Page 3
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025
Achievements and performance
a. Key performance indicators
-
424 early career writers participated in the Writers Programme this year
-
53 early career writers had their worked staged across the year
-
6,467 audiences watched our work in person
-
Listed amongst the “Top 10 London Theatres” in the 2024 Stage 100
b. Stage performances
Our full length productions for this year included:
- The Great Privation by Nia Akilah Robinson, directed by Carne Associate Director Kalungi Ssebandeke. The play was a finalist in our 2023 International Playwriting Award, and has subsequently had a successful OffBroadway production in spring 2025.
“The Great Privation is unquestionably a triumph, a declaration that history shapes our future, but we get to walk in it however we choose.” - Off/Stage
-
Tachwedd by Jon Berry, directed by Jac Ifan Moore. The play was originally commissioned as part of our 503Five programme and toured to The Torch, Pembrokeshire prior to its run at 503. **** “Powerful” - The Stage
-
By Their Fruits by DK FASH, directed by DK Fash. DK first came to 503 as part of a 2 night run, then a oneweek run of her piece ‘Fragments of A Complicated Mind’ back in 2020, highlighting the long-term pipeline through 503 for artists.
**** “boldly multidimensional” - The Guardian
- Bungalow by Ruth D’Silva, directed by Beth Kapila. Ruth’s play was shortlisted for the RSCs 37 Plays Folio in 2023. Having been postponed due to funding challenges, the production finally made it to the stage in Spring 2025.
*** “this is a playwright refreshingly willing to plumb the depths – or rather, like her heroine, crack open a can of worms” - The Guardian
Alongside these 3 week runs, we staged 25 short runs (1-4 nights) across our Summer, September and January short seasons. We also returned to hosting a festive production in the run up to Christmas for the first time since the pandemic. Santa and Sven by Stewart Wright played for 10 days through December, including two additional free performances for primary school children across the borough - one of which was livestreamed for over 2000 children under the age of 11.
Page 4
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025
Achievements and performance (continued)
c. Education, community, literary and artist development
The Writers Programme sold well, with an average of 65% of places filled and 39 bursary places offered, alongside 36 1-2-1 dramaturgy sessions being delivered.
Our brilliant literary team continued to work with our 503Five cohort: Joe Kerridge, Melis Aker, Asa Hayes, Shona Babayemi and Rachel Mae Brady. They underwent a number of professional development workshops, culminating in an industry sharing of their draft commissions to engage potential further support in taking the plays to production after their residency completes.
Rapid Write Response continued to progress from stride to stride, held brilliantly by our Carne Associate Director Kalungi Ssebandeke and then Carne Deputy Artistic Director Rochelle Wilson. It has continued to open up a pathway to future collaborations and opportunities with early career artists, platforming 6 writers’ responses to every 3-week run we programme. Across the year we platformed 24 new plays and received 138 submissions, and mentored over 50 first time directors.
Our 2024/25 International Playwriting Award opened for submissions in spring 2024, with 1377 submissions received from 49 countries. Throughout the year, our Literary team led a reading pool of 20 through a rigorous assessment process, with longlisting and shortlisting being announced throughout the year.
In late 2024, Wandsworth secured their place as the London Borough of Culture for 2025/26. We began preproduction on a major LBOC project called The Wandsworth Way; a year long radio soap opera being delivered in partnership with the Council and Riverside Radio. The project will engage over 100 community participants from the borough as writers and actors, led by lead writer James Fritz and lead director Pam Fraser-Solomon.
Page 5
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025
Achievements and performance (continued)
d. Factors relevant to achieve objectives
Artistic values
-
Diversity begins with who is telling the stories and informs how we run our venue throughout the year.
-
Theatre503 is aware that artistic tastes are not the same for everyone. The theatre therefore tries to make clear the themes and issues that the work contains on its website and in marketing materials.
-
Theatre503 takes the views of audiences very seriously and without compromising the integrity of the programme, seeks to respect the diverse ethnicity, faith, sexual orientation, and lifestyles of the community and audiences.
Pricing policy
-
The theatre's pricing policy reflects its strategy of enabling all within its community, whatever their means, to take part in its activities and to attend the theatre. We increased top price tickets to £22 to support financial sustainability whilst still ensuring out accessible price points remained.
-
Theatre503 continues to be on a par with, or cheaper than, other London theatres of similar size.
-
A concession ticket of £18 is available to students, senior citizens, members of Equity and BECTU.
-
The same discount is available to those with access requirements, with a free ticket for a companion.
-
Writers can access £8 tickets during previews, and full priced preview tickets are £15.
-
There are also 6 x £6 available for all evening shows after Press Nights.
Accessibility
-
Our Share the Drama Scheme means we subsidise around 50% of our tickets.
-
Theatre503’s customers are given the opportunity to "Pay what you Can" for performances on one Saturday Matinee and one Evening performance, ensuring work is accessible to all, regardless of income.
-
Parent & Baby Matinees and Relaxed performances continue to build an audience.
-
Trustees recognise the restrictions the current premises pose to some visitors and continue to seek to improve accessibility in areas where the opportunity exists.
Financial review
a. Reserves policy
We aim for our reserves to be equivalent of 3 months running costs, valued in 2021 at £44,000. We will review this valuation at the 2025 AGM.
Total reserves at the end of the financial year were £580,196 (2024: £226,971) of which £61,531 (2024: £159,253) were restricted, £455,854 (2024: £65,348) were unrestricted designated capital funds and £62,811 (2024: £2,370) were unrestricted general funds.
b. Going concern
After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future, in the understanding of the increased risk posed as a result of the pandemic. For this reason they continue to adopt the going concern basis in preparing the financial statements.
Page 6
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
(A company limited by guarantee)
THEATRE503 LIMITED
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025
c. Financial review
Our production of The Great Privation did not receive project funding (equating £30,000) from the Arts Council (as with A Woman Walks into a Bank in 2023). It was once again deemed critical that we committed to the production so as to deliver our charitable and artistic objectives. It was known that this decision would put strain on our resources, however, given its programming at the start of the financial year, we felt confident in allocating resources from our Slate fund and increasing fundraising targets elsewhere throughout the year.
Having ended 2023/24 with a deficit, emphasis was placed on increasing momentum with fundraising and diversifying income streams. We successfully increased our Trusts and Foundations income by over 100%, as well as our largest multi-year project grant from the Arts Council for organisational development project 503Engine which will see us partner with commercial producers to stage our work, and launch 503Productions to produce at scale across the country.
Alongside this, we hosted our first ever fundraising gala at the 503Studio, raising an additional £24k towards our core delivery, securing pledges equating to £50k for our capital fund and developing our network of supporters.
We felt the impact in our expenditure of running two buildings, with increased overheads, however expenditure remained below forecast throughout the year due to careful financial management.
All these factors combined to create a financially successful year, which saw a surplus - allowing us to rebuild our general reserve fund to £61,531, up from £2,370 following the deficit year of 2023/24.
Following careful review of our financial processes, we adopted an accrual policy for our grant income, to match earned and commercial income processes, rather than a cash based policy. In line with this, a grant for £100,000 by Backstage Trust towards our 503Studio Capital Project, which was confirmed in March 2024 but not accrued within our previous accounts due to cash based processing, has been adjusted to fall within the previous financial year. Adjustments of this income are highlighted within our accounts for this year.
We recognise that the financial and fundraising climate remains incredibly challenging, but feel confident that our increased and diversified income streams place us in a stronger position than ever before to react and respond dynamically, and build a more sustainable financial future.
d. Principal funding
The majority of the charity's income has continued to derive from box office income, tax credit claims from DCMS, Arts Council England grants, The Carne Trust, Wandsworth Borough Council, Concord Theatricals, Trusts & Foundations (see below) and individual donors.
We received grants from the following Trusts & Foundations within the year: De Laszlo Foundation, Noël Coward Foundation, Fenton Arts Trust, Mila Charitable Organisation, Garrick Trust, Backstage Trust, Chalk Cliff Trust, Idlewild Trust and the Orseis Trust.
e. Capital project
We have accounted accurately for all capital income, with expenditure on the fit-out being realised on our balance sheet as a depreciating asset.
Page 7
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025
Structure, governance and management
a. Constitution
The Charity was incorporated on 1 February 2006 under the Companies Act 1985 as a private company limited by guarantee, having no share capital, and its objects and regulations are governed by its Memorandum and Articles of Association.
Charitable status was granted on 24 July 2006 under registered number 1115555. The principal objects of the Charity are to promote, maintain, improve and advance education particularly by the promotion of educational plays and the encouragement of the Arts including the arts of Literature, Drama, Music, Singing and Movement.
There have been no changes in the objectives since the last annual report.
b. Methods of appointment or election of Trustees
As per the Memorandum and Articles of Association of the Charity, new Trustees are appointed by ordinary resolution.
Not less than fourteen nor more than thirty five days before the date of the meeting, the Charity is given a notice that is signed by a member entitled to vote at the meeting; which states the member's intention to propose the appointment of a person as a Trustee; which contains the details that, if the person were to be appointed, the Charity would have to file at Companies House and which is signed by the person who is to be proposed to show his or her willingness to be appointed.
c. Risk management
The Trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error.
Theatre503 operates a Risk Register covering Finance, Premises, Audiences, Product, Staffing and Capacity which is reviewed regularly by Trustees. The Artistic Director and Executive Director review operating risk during operations meetings and the Trustees interrogate changes in risk as they occur.
Members' liability
The Members of the Charity guarantee to contribute an amount not exceeding £10 to the assets of the charity in the event of winding up.
The Trustees' Annual Report has been prepared in accordance with the provisions applicable to entities subject to the small companies' regime, was approved by order of the members of the board of Trustees and signed on their behalf by:
James Dacre
(Chair of the Board) October 17, 2025 Date:
Page 8
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
STATEMENT OF TRUSTEES' RESPONSIBILITIES FOR THE YEAR ENDED 31 MARCH 2025
The Trustees (who are also the directors of the Charity for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial . Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles of the Charities SORP (FRS 102);
-
make judgments and accounting estimates that are reasonable and prudent;
-
state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the board of Trustees and signed on its behalf by:
James Dacre
(Chair of the Board)
October 17, 2025 Date:
Page 9
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 MARCH 2025
Independent examiner's report to the Trustees of Theatre503 Limited ('the Charity')
I report to the charity Trustees on my examination of the accounts of the Charity for the year ended 31 March 2025.
Responsibilities and basis of report
As the Trustees of the Charity (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the Charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Charity's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent examiner's statement
Since the Charity's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of ICAEW, which is one of the listed bodies.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
-
accounting records were not kept in respect of the Charity as required by section 386 of the 2006 Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or
-
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
This report is made solely to the Charity's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Charity's Trustees those matters I am required to state to them in an Independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Charity and the Charity's Trustees as a body, for my work or for this report.
Signed:
Dated:
John Coverdale FCA (ICAEW)
MHA Chartered Acountants 2 London Wall Place, London, EC2Y 5AU
MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542).
Page 10
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 MARCH 2025
| Note Income from: Charitable activities 3 Investments 5 Total income Expenditure on: Charitable activities 6 Total expenditure Net income Transfers between funds 16 Net movement in funds Reconciliation of funds: Total funds brought forward Net movement in funds Total funds carried forward |
Restricted funds 2025 £ 586,618 - 586,618 274,221 274,221 312,397 (410,119) (97,722) 159,253 (97,722) 61,531 |
Unrestricted funds 2025 £ 374,305 4,066 378,371 337,543 337,543 40,828 410,119 450,947 67,718 450,947 518,665 |
Total funds 2025 £ 960,923 4,066 964,989 611,764 611,764 353,225 - 353,225 226,971 353,225 580,196 |
As restated Total funds 2024 £ 551,204 2,300 553,504 |
|---|---|---|---|---|
| 385,284 385,284 |
||||
| 168,220 - 168,220 |
||||
| 58,751 168,220 226,971 |
The Statement of financial activities includes all gains and losses recognised in the year.
The notes on pages 15 to 30 form part of these financial statements.
Page 11
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED (A company limited by guarantee) REGISTERED NUMBER: 05694721
BALANCE SHEET AS AT 31 MARCH 2025
| Note Fixed assets Tangible assets 11 Current assets Debtors 12 Cash at bank and in hand Current liabilities Creditors: amounts falling due within one year 13 Net current assets Total assets less current liabilities Creditors: amounts falling due after more than one year 14 Total net assets Charity funds Restricted funds 16 Unrestricted funds 16 Total funds |
142,276 89,740 232,016 (107,386) |
2025 £ 465,566 465,566 124,630 590,196 (10,000) 580,196 580,196 61,531 518,665 580,196 |
172,466 113,711 286,177 (114,179) |
As restated 2024 £ 76,973 76,973 171,998 248,971 (22,000) 226,971 226,971 159,253 67,718 226,971 |
|---|---|---|---|---|
The Charity was entitled to exemption from audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.
The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.
The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.
Page 12
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED (A company limited by guarantee) REGISTERED NUMBER: 05694721
BALANCE SHEET (CONTINUED) AS AT 31 MARCH 2025
The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:
James Dacre
(Chair of the Board)
Date: October 17, 2025
The notes on pages 15 to 30 form part of these financial statements.
Page 13
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
| STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 MARCH 2025 |
||
|---|---|---|
| Cash flows from operating activities Net cash used in operating activities Cash flows from investing activities Dividends, interests and rents from investments Purchase of tangible fixed assets Net cash used in investing activities Cash flows from financing activities Repayments of borrowing Net cash used in financing activities Change in cash and cash equivalents in the year Cash and cash equivalents at the beginning of the year Cash and cash equivalents at the end of the year The notes on pages 15 to 30 form part of these financial statements |
2025 £ 394,676 4,066 (410,713) (406,647) (12,000) (12,000) (23,971) 113,711 89,740 |
As restated 2024 £ 136,407 2,300 (65,348) (63,048) (24,000) (24,000) 49,359 64,352 113,711 |
Page 14
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED (A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
1. General information
The Charity is a company limited by guarantee, incorporated in England & Wales, company number 05694721, having its registered office at 503 Battersea Park Road, London, SW11 3BW.
The members of the company are the Trustees named on page 1. In the event of the Charity being wound up, the liability in respect of the guarantee is limited to £10 per member of the Charity.
Charitable status was granted on 24 July 2006 by the Charity Commission of England & Wales, registered number 1115555.
2. Accounting policies
2.1 Basis of preparation of financial statements
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
Theatre503 Limited meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
Prior year restatement
On review of income relating to grants recieved it was discovered a grant relating to the capital project should have been included within the previous year. The prior year figures have been restated to correctly include this amount in the correct period.
2.2 Going concern
After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future, in the understanding of the increased risk posed as a result of the pandemic. For this reason they continue to adopt the going concern basis in preparing the financial statements.
2.3 Income
All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
Grants are included in the Statement of financial activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.
Income tax recoverable in relation to donations received under Gift Aid is recognised at the time of the donation.
Creative industry tax relief claims are recognised to the extent that claims are expected to made and accepted in relation to qualifying expenditure incurred in the year.
Page 15
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
(A company limited by guarantee)
THEATRE503 LIMITED
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
2. Accounting policies (continued)
2.4 Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.
Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs.
2.5 Interest receivable
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.
2.6 Tangible fixed assets and depreciation
Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.
Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, using the straight-line method.
Depreciation is provided on the following bases:
| Long-term leasehold property | - over ten years on cost |
|---|---|
| Other fixed assets | - over ten years on cost |
2.7 Debtors
Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
2.8 Cash at bank and in hand
Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
Page 16
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
(A company limited by guarantee)
THEATRE503 LIMITED
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
2. Accounting policies (continued)
2.9 Liabilities and provisions
Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.
Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of financial activities as a finance cost.
2.10 Financial instruments
The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
2.11 Pensions
The Charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Charity to the fund in respect of the year.
2.12 Fund accounting
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.
Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.
Investment income, gains and losses are allocated to the appropriate fund.
Page 17
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
3. Income from charitable activities
| Productions Education, Community & Development Capital project Commercial income Total 2025 Productions Education, Community & Development Capital project Total 2024 as restated |
Restricted funds 2025 £ 190,353 83,950 312,315 - 586,618 As restated Restricted funds 2024 £ 49,062 16,000 193,000 258,062 |
Unrestricted funds 2025 £ 207,392 159,984 - 6,929 374,305 Unrestricted funds 2024 £ 172,456 120,686 - 293,142 |
Total funds 2025 £ 397,745 243,934 312,315 6,929 960,923 |
|---|---|---|---|
| As restated Total funds 2024 £ 221,518 136,686 193,000 551,204 |
Page 18
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
4. Government grants
| Arts Council England Wandsworth Council Gift Aid claims Theatre tax relief claims Employment Allowance |
2025 £ 31,950 25,290 12,705 115,567 5,000 190,512 |
2024 £ 17,354 - 13,381 37,722 5,000 73,457 |
|---|---|---|
There were no unfulfilled commitments or other contingencies associated with the above grants at the end of the financial year.
5. Investment income
| Bank interest received Total 2024 |
Unrestricted funds 2025 £ 4,066 2,300 |
Total funds 2025 £ 4,066 2,300 |
Total funds 2024 £ 2,300 |
|---|---|---|---|
6. Analysis of expenditure on charitable activities Summary by fund type
| Productions Education, Community & Development Total 2025 |
Restricted funds 2025 £ 209,842 64,379 274,221 |
Unrestricted funds 2025 £ 67,016 270,527 337,543 |
Total 2025 £ 276,858 334,906 611,764 |
|---|---|---|---|
Page 19
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
6. Analysis of expenditure on charitable activities (continued)
Summary by fund type (continued)
| Productions Education, Community & Development Total 2024 |
Restricted funds 2024 £ 22,503 38,275 60,778 |
Unrestricted funds 2024 £ 291,645 32,861 324,506 |
Total 2024 £ 314,148 71,136 385,284 |
|---|---|---|---|
Page 20
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
7. Analysis of expenditure by activities
| Productions Education, Community & Development Total 2025 |
Activities undertaken directly 2025 £ 71,499 182,329 253,828 |
Support costs 2025 £ 205,359 152,577 357,936 |
Total funds 2025 £ 276,858 334,906 611,764 |
|---|---|---|---|
| Productions Education, Community & Development Total 2024 |
Activities undertaken directly 2024 £ 86,952 19,672 106,624 |
Support costs 2024 £ 227,196 51,464 278,660 |
Total funds 2024 £ 314,148 71,136 385,284 |
|---|---|---|---|
Page 21
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
7. Analysis of expenditure by activities (continued)
Analysis of support costs
| Staff costs Depreciation Theatre and building Nine Elms running costs Fees Interest Marketing, administration and finance Total 2025 Independent examiner's remuneration Fees payable to the Charity's independent examiner for the independent examination of the Charity's annual accounts Fees payable to the Charity's independent examiner in respect of: All other services not included above |
Total funds 2025 £ 268,787 22,120 19,443 8,848 7,870 503 30,365 357,936 2025 £ 7,000 2,650 |
Total funds 2024 £ 205,982 2,508 20,416 5,144 8,100 901 35,609 278,660 |
|---|---|---|
| 2024 £ 4,000 3,850 |
8. Independent examiner's remuneration
Page 22
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
9. Staff costs
| Wages and salaries Social security costs Contributions to defined contribution pension schemes |
2025 £ 246,821 16,764 5,202 268,787 |
2024 £ 191,579 10,399 4,004 |
|---|---|---|
| 205,982 |
The average number of persons employed by the Charity during the year was as follows:
| Operations Charitable activities |
2025 No. 2 8 10 |
2024 No. 3 5 |
|---|---|---|
| 8 |
No employee received remuneration amounting to more than £60,000 in either year.
The Trustees of the Charity considers that its Key Management Personnel comprise:
-
Trustees
-
Artistic Director
-
Executive Director
The total of employee benefits for Key Management Personnel was £81,271 (2024 - £66,002) .
10. Trustees' remuneration and expenses
During the year, no Trustees received any remuneration or other benefits (2024 - £NIL) .
During the year ended 31 March 2025, no Trustee expenses have been incurred (2024 - £NIL) .
Page 23
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
11. Tangible fixed assets
| Cost or valuation At 1 April 2024 Additions At 31 March 2025 Depreciation At 1 April 2024 Charge for the year At 31 March 2025 Net book value At 31 March 2025 At 31 March 2024 |
Long-term leasehold property £ 65,348 410,119 475,467 - 19,613 19,613 455,854 65,348 |
Other fixed assets £ 24,349 594 24,943 12,724 2,507 15,231 9,712 11,625 |
Total £ 89,697 410,713 500,410 |
|---|---|---|---|
| 12,724 22,120 34,844 |
|||
| 465,566 | |||
| 76,973 |
The Nine Elms project is currently in the course of construction.
12. Debtors
| Due within one year Trade debtors Other debtors Prepayments and accrued income Tax recoverable |
2025 £ 15,083 11,626 - 115,567 142,276 |
As restated 2024 £ 47,203 4 100,000 25,259 172,466 |
|---|---|---|
Page 24
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
13. Creditors: Amounts falling due within one year
| Bank overdrafts Other loans Trade creditors Other taxation and social security Other creditors Accruals and deferred income Deferred income at 1 April 2024 Resources deferred during the year Amounts released from previous periods |
2025 £ 616 12,000 56,745 4,426 2,656 30,943 107,386 2025 £ 70,000 10,943 (50,000) 30,943 |
2024 £ - 12,000 16,063 8,377 7,739 70,000 |
|---|---|---|
| 114,179 | ||
| 2024 £ 50,000 70,000 (50,000) |
||
| 70,000 |
The Cockayne grant of £50,000 designated for RIBA Stage 4 of our Nine Elms development was deferred during the year to 31 March 2023 pending the formal start of the phase which began in October 2023. Contributions totalling £50,000 received from Concord, Eilene Davidson and Dynamis Ltd received during the year to 31 March 2024 were deferred to phases due to commence in 2024/25 and £20,000 from Concord deferred to 2025/26. A further £10,943 received in the year to 31 March 2025 from Arts Council England for the 503Engine project has been deferred to 2025/26.
14. Creditors: Amounts falling due after more than one year
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Other loans | 10,000 | 22,000 |
15. Prior year adjustments
Restricted grant income of £100,000 was originally accounted for when received in April 2024. In compiling these financial statements this income was identified as having been confirmed by the grantor in March 2024 and accordingly the comparative figures have been restated with Restricted income for the year to 31 March 2024, Debtors and the Restricted fund balance at 31 March 2024 all £100,000 greater than originally stated in the 2023/24 financial statements.
Page 25
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
16. Statement of funds
Statement of funds - current year
| Unrestricted funds Designated funds Nine Elms capital spend General funds General Fund Total Unrestricted funds Restricted funds Slate managed funds assessor 503Five 503Engine Rapid Write Response Playwriting Award Wandsworth Writes Carne Associate Director Capital project Production contributions Total of funds |
Balance at 1 April 2024 £ 65,348 2,370 67,718 Balance at 1 April 2024 £ - 13,634 - - - 1,447 - 144,172 - 159,253 226,971 |
Income £ - 378,371 378,371 Income £ 4,450 11,000 27,500 4,000 13,000 - 24,000 312,315 190,353 586,618 964,989 |
Expenditure £ (19,613) (317,930) (337,543) Expenditure £ (4,450) (16,937) (27,500) (4,000) (9,900) (1,447) (19,634) - (190,353) (274,221) (611,764) |
Transfers in/out £ 410,119 - 410,119 Transfers in/out £ - - - - - - - (410,119) - (410,119) - |
Balance at 31 March 2025 £ 455,854 |
|---|---|---|---|---|---|
| 62,811 | |||||
| 518,665 | |||||
| Balance at 31 March 2025 £ - 7,697 - - 3,100 - 4,366 46,368 - 61,531 |
|||||
| 580,196 |
Page 26
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
16. Statement of funds (continued)
Statement of funds - prior year
| Unrestricted funds Designated funds Nine Elms capital spend General funds General Fund Total Unrestricted funds Restricted funds Playwriting Award Wandsworth Writes Amortisation Carne Associate Director Production contributions Concorde Theatrical 503Five Capital project Total of funds |
Balance at 1 April 2023 £ - 30,822 30,822 - 2,059 - - - 6,000 3,350 16,520 27,929 58,751 |
As restated Income £ - 295,442 295,442 1,779 - 1,000 13,000 33,283 - 16,000 193,000 258,062 553,504 |
Expenditure £ - (324,506) (324,506) (1,779) - (1,000) (13,000) (33,283) (6,000) (5,716) - (60,778) (385,284) |
Transfers in/out £ 65,348 612 65,960 - (612) - - - - - (65,348) (65,960) - |
Balance at 31 March 2024 £ 65,348 |
|---|---|---|---|---|---|
| 2,370 | |||||
| 67,718 | |||||
| - 1,447 - - - - 13,634 144,172 159,253 |
|||||
| 226,971 |
Page 27
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
(A company limited by guarantee)
THEATRE503 LIMITED
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
16. Statement of funds (continued)
Designated funds
Relating to the Nine Elms capital project representing the amount spent to date less depreciation charged.
.
General funds
Held to cover future running costs.
Restricted funds
Representing restricted funds received for specific projects less amounts spent thereon. Transfers to the Designated fund correspond to the amount spent on the Nine Elms capital project.
17. Analysis of net assets between funds
Analysis of net assets between funds - current year
| Tangible fixed assets Current assets Creditors due within one year Creditors due in more than one year Total |
Restricted funds 2025 £ - 61,531 - - 61,531 |
Unrestricted funds 2025 £ 465,566 170,485 (107,386) (10,000) 518,665 |
Total funds 2025 £ 465,566 232,016 (107,386) (10,000) 580,196 |
|---|---|---|---|
Analysis of net assets between funds - prior year
| Tangible fixed assets Current assets Creditors due within one year Creditors due in more than one year Total |
Restricted funds 2024 £ - 229,253 (82,000) 12,000 159,253 |
Unrestricted funds 2024 £ 76,973 56,924 (32,179) (34,000) 67,718 |
Total funds 2024 £ 76,973 286,177 (114,179) (22,000) 226,971 |
|---|---|---|---|
Page 28
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
18. Reconciliation of net movement in funds to net cash flow from operating activities
| Net income for the year (as per Statement of Financial Activities) Adjustments for: Depreciation charges Dividends, interests and rents from investments Decrease/(increase) in debtors Decrease in creditors Net cash provided by operating activities 19. Analysis of cash and cash equivalents Cash in hand Total cash and cash equivalents 20. Analysis of changes in net debt At 1 April 2024 £ Cash at bank and in hand 113,711 Bank overdrafts repayable on demand - Debt due within 1 year (12,000) Debt due after 1 year (22,000) 79,711 |
2025 £ 353,225 22,120 (4,066) 30,190 (6,793) 394,676 2025 £ 89,740 89,740 Cash flows £ (23,971) (616) - 12,000 (12,587) |
2024 £ 168,220 2,508 (2,300) (9,767) (22,254) 136,407 2024 £ 113,711 113,711 At 31 March 2025 £ 89,740 (616) (12,000) (10,000) 67,124 |
|---|---|---|
Page 29
Docusign Envelope ID: C3660D99-AAA4-466D-872E-B7FB971A099D
THEATRE503 LIMITED
(A company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
21. Pension commitments
The Charity operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the group in an independently administered fund.
The pension cost charge represents contributions payable by the Charity to the fund and amounted to £5,202 (2024: £4,004) .
Contributions of £2,656 (2024: £5,762) were payable to the fund at the balance sheet date and are included in creditors.
22. Related party transactions
The aggregate amount of donations made by trustees or connected parties without conditions during the year was £581 (2024: £5,000) .
Eleanor Lloyd, a trustee, provided advances to support the charity's cash flow as part of the initial move to the new operating model. £22,000 (2024: £34,000) was outstanding at the end of the year.
Jack Tilbury, a trustee, is a director of Plann Ltd appointed as project manager to lead our Capital project for the development of our new studio space. The charity paid £51,642 (2024: £11,920) in fees related to this project during the year.
There were no other material related party transactions requiring disclosure during the period (2024: None) .
Page 30